Cargando…

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases

Anti-tumour necrosis factor (TNF)-α agents have been increasingly used to treat patients affected by inflammatory bowel disease and dermatological and rheumatologic inflammatory disorders. However, the widening use of biologics is related to a new class of adverse events called paradoxical reactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopetuso, Loris Riccardo, Cuomo, Claudia, Mignini, Irene, Gasbarrini, Antonio, Papa, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179362/ https://www.ncbi.nlm.nih.gov/pubmed/37175894 http://dx.doi.org/10.3390/ijms24098187

Ejemplares similares

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2018)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase
por: Papa, Alfredo, et al.
Publicado: (2020)

When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach
por: Tursi, Antonio, et al.
Publicado: (2022)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
por: Covino, Marcello, et al.
Publicado: (2021)

Human herpesvirus 8-associated colonic Kaposi’s sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature
por: Papa, Valerio, et al.
Publicado: (2020)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats
por: Shuwa, Halima Ali, et al.
Publicado: (2018)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy
por: Nakayama, Satoshi
Publicado: (2013)

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Polymorphisms in Tumour Necrosis Factor Alpha (TNFα) Gene in Patients with Acute Pancreatitis
por: Özhan, Gül, et al.
Publicado: (2010)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative Colitis
por: Liso, Marina, et al.
Publicado: (2022)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

Tumour necrosis factor-alpha (TNFα) stimulates the growth of human bone marrow stromal cells
por: Rougier, F., et al.
Publicado: (1997)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Iatrogenic Kaposi Sarcoma Precipitated by Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy
por: Mariappan, Aathi Lakshmi, et al.
Publicado: (2021)

Gut Microbiota Profiling and Gut–Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
por: Quagliariello, Andrea, et al.
Publicado: (2018)

Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression
por: Ghorbani, Masoud, et al.
Publicado: (2012)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Tumour necrosis factor (TNF)-α-308 gene polymorphism in Indian patients with Takayasu's arteritis - A pilot study
por: Sandhya, P., et al.
Publicado: (2013)

Ceramide Kinase Regulates the Production of Tumor Necrosis Factor α (TNFα) via Inhibition of TNFα-converting Enzyme
por: Lamour, Nadia F., et al.
Publicado: (2011)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes
por: Robak, E., et al.
Publicado: (1996)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Anti‐inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization
por: Assas, B. M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b41ot47t50223rda3avocru65v